Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Oculis Holding AG (NASDAQ : OCS) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Quote
| Last: | $11.10 |
|---|---|
| Change Percent: | 2.83% |
| Open: | $10.9 |
| Close: | $10.795 |
| High: | $11.6 |
| Low: | $10.86 |
| Volume: | 257,697 |
| Last Trade Date Time: | 06/10/2026 12:42:45 pm |
Stock Data
| Market Cap: | $1,527,387,432 |
|---|---|
| Float: | 49,696,926 |
| Insiders Ownership: | N/A |
| Institutions: | 16 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.oculis.com |
| Country: | CH |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Oculis Holding AG (NASDAQ: OCS).
